Increased Bovine Tim-3 and Its Ligand Expressions During Bovine Leukemia Virus Infection
Overview
Authors
Affiliations
The immunoinhibitory receptor T cell immunoglobulin domain and mucin domain-3 (Tim-3) and its ligand, galectin-9 (Gal-9), are involved in the immune evasion mechanisms for several pathogens causing chronic infections. However, there is no report concerning the role of Tim-3 in diseases of domestic animals. In this study, cDNA encoding for bovine Tim-3 and Gal-9 were cloned and sequenced, and their expression and role in immune reactivation were analyzed in bovine leukemia virus (BLV)-infected cattle. Predicted amino acid sequences of Tim-3 and Gal-9 shared high homologies with human and mouse homologues. Functional domains, including tyrosine kinase phosphorylation motif in the intracellular domain of Tim-3 were highly conserved among cattle and other species. Quantitative real-time PCR analysis showed that bovine Tim-3 mRNA is mainly expressed in T cells such as CD4+ and CD8+ cells, while Gal-9 mRNA is mainly expressed in monocyte and T cells. Tim-3 mRNA expression in CD4+ and CD8+ cells was upregulated during disease progression of BLV infection. Interestingly, expression levels for Tim-3 and Gal-9 correlated positively with viral load in infected cattle. Furthermore, Tim-3 expression level closely correlated with up-regulation of IL-10 in infected cattle. The expression of IFN-γ and IL-2 mRNA was upregulated when PBMC from BLV-infected cattle were cultured with Cos-7 cells expressing Tim-3 to inhibit the Tim-3/Gal-9 pathway. Moreover, combined blockade of the Tim-3/Gal-9 and PD-1/PD-L1 pathways significantly promoted IFN-γ mRNA expression compared with blockade of the PD-1/PD-L1 pathway alone. These results suggest that Tim-3 is involved in the suppression of T cell function during BLV infection.
Scull T, Strieder-Barboza C, Benitez O Pathogens. 2024; 13(10).
PMID: 39452756 PMC: 11510436. DOI: 10.3390/pathogens13100885.
Sharma S, Sharma K, Kumar R, Dayal D, Dhanda S, Kumar N Pathogens. 2024; 13(6).
PMID: 38921771 PMC: 11206971. DOI: 10.3390/pathogens13060473.
The role, relevance and management of immune exhaustion in bovine infectious diseases.
Sharma S, Kumar N, Rouse B, Sharma K, Chaubey K, Singh S Heliyon. 2024; 10(7):e28663.
PMID: 38596123 PMC: 11002068. DOI: 10.1016/j.heliyon.2024.e28663.
The Global Epidemiology of Bovine Leukemia Virus: Current Trends and Future Implications.
Lv G, Wang J, Lian S, Wang H, Wu R Animals (Basel). 2024; 14(2).
PMID: 38254466 PMC: 10812804. DOI: 10.3390/ani14020297.
Combined Immune Checkpoint Blockade Enhances Antiviral Immunity against Bovine Leukemia Virus.
Nakamura H, Konnai S, Okagawa T, Maekawa N, Sajiki Y, Watari K J Virol. 2023; 97(1):e0143022.
PMID: 36598199 PMC: 9888214. DOI: 10.1128/jvi.01430-22.